Literature DB >> 12941994

Who should be treated with combination therapy as initial treatment for hypertension?

George L Bakris1.   

Abstract

There is currently consensus regarding the need to initiate antihypertensive therapy with a combination of two agents from different antihypertensive classes in selected patients. This consensus extends to the need to bring blood pressure to the appropriate level but has not been defined regarding optimal strategies for selection of combinations that may be most effective at reducing the morbidity and mortality associated with hypertension. Because of the heterogeneous nature of hypertension, there may be unique population-specific strategies for selecting antihypertensive regimens. Appropriate combinations of antihypertensive agents are particularly relevant for patients with diabetes, renal disease, and isolated systolic hypertension as well as for African Americans with high-risk hypertension. The antihypertensive regimen for high-risk patients should be based on those agents for which the patient has compelling indications, with the addition of agents deemed most likely to bring the patient to the appropriate blood pressure goal as quickly as possible.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941994      PMCID: PMC8099288          DOI: 10.1111/j.1524-6175.2003.02675.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

2.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

Review 3.  Prevalence and implications of uncontrolled systolic hypertension.

Authors:  William B Kannel
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting.

Authors:  Franz H Messerli; Matthew R Weir; Joel M Neutel
Journal:  Am J Hypertens       Date:  2002-06       Impact factor: 2.689

5.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

6.  Systolic blood pressure is the main etiology for poorly controlled hypertension.

Authors:  Muhammad G Alam; Yousri M Barri
Journal:  Am J Hypertens       Date:  2003-02       Impact factor: 2.689

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey.

Authors:  C A Jones; G M McQuillan; J W Kusek; M S Eberhardt; W H Herman; J Coresh; M Salive; C P Jones; L Y Agodoa
Journal:  Am J Kidney Dis       Date:  1998-12       Impact factor: 8.860

9.  Diabetes and cardiovascular disease. The Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

10.  Pulse pressure and subclinical cardiovascular damage in primary hypertension.

Authors:  Francesca Viazzi; Giovanna Leoncini; Denise Parodi; Maura Ravera; Elena Ratto; Simone Vettoretti; Cinzia Tomolillo; Massimo Del Sette; Gian Paolo Bezante; Giacomo Deferrari; Roberto Pontremoli
Journal:  Nephrol Dial Transplant       Date:  2002-10       Impact factor: 5.992

View more
  1 in total

1.  Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients.

Authors:  Michele Adolfo Tedesco; Francesco Natale; Raffaele Calabrò
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.